{
  "id": "1aa0a20a838e9b41",
  "title": "FDA Approval Puts New Cytokinetics Heart Drug in Competition With Fast - Growing BMS Med",
  "description": "20251222T201500Z",
  "content": "",
  "source": "medcitynews.com",
  "source_url": "https://medcitynews.com/2025/12/cytokinetics-myqorvo-aficamten-fda-approval-myosin-inhibitor-hcm-cardiovascular-cytk/",
  "published_at": "20251222T201500Z",
  "fetched_at": "2025-12-23T00:22:44.609575+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://medcitynews.com/2025/12/cytokinetics-myqorvo-aficamten-fda-approval-myosin-inhibitor-hcm-cardiovascular-cytk/",
    "url_mobile": "",
    "title": "FDA Approval Puts New Cytokinetics Heart Drug in Competition With Fast - Growing BMS Med",
    "seendate": "20251222T201500Z",
    "socialimage": "https://medcitynews.com/wp-content/uploads/sites/7/2025/09/GettyImages-1349766206.jpg",
    "domain": "medcitynews.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}